Insiders · Profile

Kirkpatrick Lynn

Chief Executive Officer at Ensysce Biosciences. Filing since 25 May 2022. CIK 0001418785

Company
Date
Role
Action
Shares
Amount
Of holding
26 May 2022
Chief Executive Officer
Bought
27,000
$14.22K
7.6%
25 May 2022
Chief Executive Officer
Bought
70,000
$34.08K
24.6%
2 decisions on file.